rs2199936
From SNPedia
Orientation | plus |
Stabilized | plus |
Geno | Mag | Summary |
---|---|---|
(A;A) | ||
(G;G) | 0 | common in complete genomics |
(T;T) |
Make rs2199936(A;G) |
Reference | GRCh37.p2 37.2/134 |
Chromosome | 4 |
Position | 88124179 |
Gene | ABCG2 |
is a | snp |
is | mentioned by |
dbSNP | rs2199936 |
dbSNP (classic) | rs2199936 |
ClinGen | rs2199936 |
ebi | rs2199936 |
HLI | rs2199936 |
Exac | rs2199936 |
Gnomad | rs2199936 |
Varsome | rs2199936 |
LitVar | rs2199936 |
Map | rs2199936 |
PheGenI | rs2199936 |
Biobank | rs2199936 |
1000 genomes | rs2199936 |
hgdp | rs2199936 |
ensembl | rs2199936 |
geneview | rs2199936 |
scholar | rs2199936 |
rs2199936 | |
pharmgkb | rs2199936 |
gwascentral | rs2199936 |
openSNP | rs2199936 |
23andMe | rs2199936 |
SNPshot | rs2199936 |
SNPdbe | rs2199936 |
MSV3d | rs2199936 |
GWAS Ctlg | rs2199936 |
Max Magnitude | 0 |
? | (A;A) (A;G) (G;G) | 28 |
---|---|---|
|
GWAS snp | |
---|---|
PMID | [PMID 20884846] |
Trait | |
Title | Multiple Genetic Loci Influence Serum Urate And Their Relationship With Gout and Cardiovascular Disease Risk Factors |
Risk Allele | A |
P-val | 1E-75 |
Odds Ratio | 18.08 [16.16-20.00] umol/l increase |
GWAS snp | |
---|---|
PMID | [PMID 21943158] |
Trait | |
Title | Genetic variants in LPL, OASL and TOMM40/APOE-C1-C2-C4 genes are associated with multiple cardiovascular-related traits. |
Risk Allele | A |
P-val | 2E-17 |
Odds Ratio | 0.1880 [0.14-0.23] umol/l increase |
[PMID 19503597] Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations.
GWAS snp | |
---|---|
PMID | [PMID 23118302] |
Trait | Lipoprotein-associated phospholipase A2 activity change in response to statin therapy |
Title | Genome-wide association study evaluating lipoprotein-associated phospholipase A2 mass and activity at baseline and after rosuvastatin therapy. |
Risk Allele | A |
P-val | 2E-10 |
Odds Ratio | 2.80 [1.82-3.78] percent decrease |
[PMID 26427508] Serum urate gene associations with incident gout, measured in the Framingham Heart Study, are modified by renal disease and not by body mass index